Silexion Therapeutics announces 1-for-15 reverse share split to maintain Nasdaq listing

Silexion Therapeutics Corp

Reverse split effective after market close July 28; split-adjusted trading starts July 29 under ticker SLXN.
Every 15 ordinary shares combined into 1; fractional shares rounded up to nearest whole share.
Par value increases from $0.0009 to $0.0135 per share; no action required from shareholders.
Split designed to regain compliance with Nasdaq minimum bid price rule (Listing Rule 5550(a)(2)).
CEO Ilan Hadar states split supports strategic growth initiatives and capital markets positioning.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.